Results

Labcorp Holdings Inc.

02/10/2025 | Press release | Distributed by Public on 02/10/2025 08:16

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Schroeder Mark S
2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [LH] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP, Pres Diagnostics & COO
(Last) (First) (Middle)
531 SOUTH SPRING STREET 		3. Date of Earliest Transaction (Month/Day/Year)
02/06/2025
(Street)
BURLINGTON, NC 27215 		4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/06/2025 M 743 A (1) 5,779.1426 D
Common Stock 02/06/2025 F(2) 210 D $247.74 5,569.1426 D
Common Stock 02/07/2025 M 517 A (1) 6,086.1426 D
Common Stock 02/07/2025 F(2) 146 D $246.27 5,940.1426 D
Common Stock 02/07/2025 M 164 A (1) 6,104.1426 D
Common Stock 02/07/2025 F(2) 47 D $246.27 6,057.1426 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 02/06/2025 M 743 (3) (3) Common Stock 743 $ 0 3,322(4) D
Restricted Stock Unit (1) 02/07/2025 M 517 (5) (5) Common Stock 517 $ 0 2,805(4) D
Restricted Stock Unit (1) 02/07/2025 M 164 (5) (5) Common Stock 164 $ 0 2,641(4) D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Schroeder Mark S
531 SOUTH SPRING STREET
BURLINGTON, NC 27215 		EVP, Pres Diagnostics & COO

Signatures

/s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder 02/10/2025
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.
(2) Stock withholding to satisfy tax withholding obligations.
(3) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
(4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
(5) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

Remarks:
On May 17, 2024, LHI became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.